SARS-CoV-2 detection using real-time RT-PCR and the relationship between immunological markers Interleukin -4, Interleukin -6 and SARS-CoV-2 patient groups

https://doi.org/10.53730/ijhs.v6nS1.7192

Authors

  • Mustafa Raheem Tuamah Master student in Babylon University/ Collage Sciences for Woman
  • Ishraq Abdul Ameer Salih Department of Biology Science for Women, University of Babylon

Keywords:

S gene, E gene, N gene, Interleukin-4, Interleukin-6, SARS-CoV-2

Abstract

Abstract: Coronaviruses (CoVs) refer to one of the RNA virus infections can showed as one of diseases virus effect of humans. They're wrapped infections with massive single-strand positive sense RNA genomes that can infect humans, animals, birds, bats, mice, and a number of other wild creatures' respiratory, gastrointestinal, hepatic, and focused sensory systems. Material and Method: viral 90 patients, a nasopharyngeal swab can be focused on a lot. COVID-19 and non-COVID-19 serum patients cytokines were identified by ELISA, while SARS-CoV-2 IL-4and, IL-6 were recognized by chemiluminescence method. Results: S quality is generally present in the early stages of contamination, with only a few extended stretches of contamination, whereas E quality is present in the late stages of disease, north of 1 - several weeks after the start of contamination, as well as N quality to a lesser extent. With 90% amino corrosive homology and less modifications over time, the N quality is more regulated and stable. The (S and/E quality) heterozygote has a higher rate than the others.

Downloads

Download data is not yet available.

References

Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F.,(2020). Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin. Infect. Dis.71, 778–785.

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 395(10223):514–523 .

World Health Organization. (2020). Coronavirus disease (COVID-19) pandemic.

Yu Chen, Qianyun Liu, and Deyin Guo.(2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis J Med Virol. Apr; 92(4): 418–423.

Peng Zhou, Xing-Lou Yang, Zheng-Li Shi. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature Research Journal , Nature volume. 579, pages270–273.

Trevor R. F. Smith, Ami Patel, Kate E. (2020). Broderick Immunogenicity of a DNA vaccine candidate for COVID-19 Nature Communications volume 11, Article number: 2601 .

Marra MA, Jones SJM, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YSN, Khattra J, Asano JK, Barber SA, Chan SY, Cloutier A, Coughlin SM, Freeman D, Girn N, Griffith OL, Leach SR, Mayo M, McDonald H, Montgomery SB, Pandoh PK, Petrescu AS. (2003). The genome sequence of the SARS-associated coronavirus. Science .;300:1399–1404.

Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW. (2003). Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med.;348:1967–1976.

Grifoni A, Sidney J, Zhang Y, Scheuermann RH, Peters B, Sette A. (2020). A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2. Cell Host Microbe. 8 April.

Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. (2003). Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science.;300:1394–1399.

Zhu Y, Liu M, Zhao W, Zhang J, Zhang X, Wang K, Gu C, Wu K, Li Y, Zheng C, Xiao G, Yan H, Zhang J, Guo D, Tien P, Wu J. (2005). Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates. Virus Genes.;30:93–102.

Holmes KV, Enjuanes L. (2003). Virology. The SARS coronavirus: a postgenomic era. Science.;300:1377–1378.

Ishraq Abdul Amir Saleh .(2020) , TUMOR NECROSIS FACTOR-± (TNF-±) 308 G/A PROMOTER POLYMORPHISMS IN GASTRIC CANCERS PATIENTS IN IRAQ Plant Archives Vol. 20 No. 2, pp. 8667-8670.

Cong Y, Ulasli M, Schepers H, Mauthe M, V’Kovski P, Kriegenburg F, Thiel V, de Haan CAM, Reggiori F. (2020). Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle. J Virol.;94:e01925-19.

Leung DT, Tam FC, Ma CH, Chan PK, Cheung JL, Niu H, Tam JS, Lim PL. (2004). Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. J Infect Dis. .;190:379–386.

Günter Kampf. (2021). COVID-19: stigmatising the unvaccinated is not justified.The Lancet..398,10314,1871.

Mohammed Yousif Merza, Rundk Ahmed Hwaiz, Badraldin Kareem Hamad, Karzan Abdulmuhsin Mohammad, Harmand Ali Hama, and Abdulkarim Yasin Karim. (2021). Analysis of cytokines in SARS-CoV-2 or COVID-19 patients in Erbil city, Kurdistan Region of Iraq. PLoS One.; 16(4): e0250330.

Dudley J, Leidos Inc, Alexandria VA. . (2022). COVID-19 Transmission Under the Public Health Radar: High Prevalence in Young Adults for COVID-19 Pandemic Wave 1Elsevier.

Víctor J. Costela-Ruiz, Rebeca Illescas-Montes, Jose M. Puerta-Puerta,c Concepción Ruiz, and Lucia Melguizo-Rodríguez. (2020). SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Pudmed cental.

Jian-Min Jin, Peng Bai, Wei He, Fei Wu, Xiao-Fang Liu, De-Min Han, Shi Liu and Jin-Kui Yang. (2020). Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers Public Health.

Bin Huang, Yun Cai, Ning Li, Kening Li, Zhihua Wang, Lu Li, Lingxiang Wu, Mengyan Zhu, Jie Li, Ziyu Wang, Min Wu, Wanlin Li, Wei Wu, Lishen Zhang, Xinyi Xia, Shukui Wang, Hongshan Chen & Qianghu Wang. (2021). Sex-based clinical and immunological differences in COVID-19. BMC Infectious Diseases.

New CDC Study.(2021). Vaccination Offers Higher Protection than Previous COVID-19 Infection. CDC Newsroom.

Víctor J. Costela-Ruiz, Rebeca Illescas-Montes, Jose M. Puerta-Puerta, Concepción Ruiz, and Lucia Melguizo-Rodrígueza. (2020). SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. PMC.

Published

11-05-2022

How to Cite

Tuamah, M. R. ., & Salih, I. A. A. (2022). SARS-CoV-2 detection using real-time RT-PCR and the relationship between immunological markers Interleukin -4, Interleukin -6 and SARS-CoV-2 patient groups. International Journal of Health Sciences, 6(S1), 9508–9517. https://doi.org/10.53730/ijhs.v6nS1.7192

Issue

Section

Peer Review Articles